AI SummaryIndia's AYUSH sector is poised for ₹8,000–12,000 crore global opportunity following the EU FTA (Dec 2023) and doubled ministry budget (2026-27), but small manufacturers lack regulatory expertise to certify products for international markets. A compliance and certification service addressing this gap—bridging traditional knowledge with clinical evidence—can charge ₹3–8 lakh per product certification and ₹10–25 lakh per clinical trial project. This business is ideal for MBAs, regulatory consultants, or health professionals in AYUSH hubs (Bangalore, Hyderabad, Kochi, Delhi), with 30–40% net margins by year 2 and first-mover advantage in a ₹12,000 Cr emerging export market.
Loading...